Treatment-related gastrointestinal toxicities and advanced colorectal or pancreatic cancer: A critical update

by Aprile, Giuseppe, Rihawi, Karim, De Carlo, Elisa, Sonis, Stephen T
Published in World J Gastroenterol (2015)

Ramucirumab: preclinical research and clinical development

by Aprile, Giuseppe, Rijavec, Erika, Fontanella, Caterina, Rihawi, Karim, Grossi, Francesco
Published in Onco Targets Ther (2014)

Chemotherapy treatment in malignant pleural mesothelioma: a difficult history

by Cinausero, Marika, Rihawi, Karim, Sperandi, Francesca, Melotti, Barbara, Ardizzoni, Andrea
Published in J Thorac Dis (2018)

Pembrolizumab in the treatment of metastatic non-small cell lung cancer: a review of current evidence

by Rihawi, Karim, Gelsomino, Francesco, Sperandi, Francesca, Melotti, Barbara, Fiorentino, Michelangelo, Casolari, Laura, Ardizzoni, Andrea
Published in Ther Adv Respir Dis (2017)

Treatment of Metastatic Breast Cancer in a Real-World Scenario: Is Progression-Free Survival With First Line Predictive of Benefit From Second and Later Lines?

by Bonotto, Marta, Gerratana, Lorenzo, Iacono, Donatella, Minisini, Alessandro Marco, Rihawi, Karim, Fasola, Gianpiero, Puglisi, Fabio
Published in Oncologist (2015)

Hyperglycemia and Phosphatidylinositol 3-Kinase/Protein Kinase B/Mammalian Target of Rapamycin (PI3K/AKT/mTOR) Inhibitors in Phase I Trials: Incidence, Predictive Factors, and Mana...

by Khan, Khurum H., Wong, Mabel, Rihawi, Karim, Bodla, Shankar, Morganstein, Daniel, Banerji, Udai, Molife, Lulama R.
Published in Oncologist (2016)

Novel HER2-Directed Treatments in Advanced Gastric Carcinoma: AnotHER Paradigm Shift?

by Ricci, Angela Dalia, Rizzo, Alessandro, Rojas Llimpe, Fabiola Lorena, Di Fabio, Francesca, De Biase, Dario, Rihawi, Karim
Published in Cancers (Basel) (2021)

Real-time tests of multiple genome alterations take the first steps into the clinic: a learning example

by Gerratana, Lorenzo, De Maglio, Giovanna, De Pellegrin, Alessandro, Follador, Alessandro, Rihawi, Karim, Pizzolitto, Stefano, Puglisi, Fabio, Fasola, Gianpiero
Published in Onco Targets Ther (2016)

Roles of IL-1 in Cancer: From Tumor Progression to Resistance to Targeted Therapies

by Gelfo, Valerio, Romaniello, Donatella, Mazzeschi, Martina, Sgarzi, Michela, Grilli, Giada, Morselli, Alessandra, Manzan, Beatrice, Rihawi, Karim, Lauriola, Mattia
Published in Int J Mol Sci (2020)

Reliability of programmed death ligand 1 (PD-L1) tumor proportion score (TPS) on cytological smears in advanced non-small cell lung cancer: a prospective validation study

by Ricci, Costantino, Capizzi, Elisa, Giunchi, Francesca, Casolari, Laura, Gelsomino, Francesco, Rihawi, Karim, Natali, Filippo, Livi, Vanina, Trisolini, Rocco, Fiorentino, Michelangelo, Ardizzoni, Andrea
Published in Ther Adv Med Oncol (2020)

Tumor-Associated Macrophages and Inflammatory Microenvironment in Gastric Cancer: Novel Translational Implications

by Rihawi, Karim, Ricci, Angela Dalia, Rizzo, Alessandro, Brocchi, Stefano, Marasco, Giovanni, Pastore, Luigi Vincenzo, Llimpe, Fabiola Lorena Rojas, Golfieri, Rita, Renzulli, Matteo
Published in Int J Mol Sci (2021)

Higher risk of infections with PI3K-AKT-mTOR pathway inhibitors in patients with advanced solid tumors on Phase I clinical trials

by Rafii, Saeed, Roda, Desamparados, Geuna, Elena, Jimenez, Begona, Rihawi, Karim, Capelan, Marta, Yap, Timothy A, Molife, L Rhoda, Kaye, Stanley B, de Bono, Johann S, Banerji, Udai
Published in Clin Cancer Res (2015)

MYC Amplification as a Potential Mechanism of Primary Resistance to Crizotinib in ALK-Rearranged Non-Small Cell Lung Cancer: A Brief Report()()

by Rihawi, Karim, Alfieri, Roberta, Fiorentino, Michelangelo, Fontana, Francesca, Capizzi, Elisa, Cavazzoni, Andrea, Terracciano, Mario, La Monica, Silvia, Ferrarini, Alberto, Buson, Genny, Petronini, Pier Giorgio, Ardizzoni, Andrea
Published in Transl Oncol (2018)

Timing and extent of response in colorectal cancer: critical review of current data and implication for future trials

by Aprile, Giuseppe, Fontanella, Caterina, Bonotto, Marta, Rihawi, Karim, Lutrino, Stefania Eufemia, Ferrari, Laura, Casagrande, Mariaelena, Ongaro, Elena, Berretta, Massimiliano, Avallone, Antonio, Rosati, Gerardo, Giuliani, Francesco, Fasola, Gianpiero
Published in Oncotarget (2015)

HER-2 inhibition in gastric and colorectal cancers: tangible achievements, novel acquisitions and future perspectives

by Fanotto, Valentina, Ongaro, Elena, Rihawi, Karim, Avallone, Antonio, Silvestris, Nicola, Fornaro, Lorenzo, Vasile, Enrico, Antonuzzo, Lorenzo, Leone, Francesco, Rosati, Gerardo, Giuliani, Francesco, Bordonaro, Roberto, Scartozzi, Mario, Maglio, Giovanna De, Negri, Francesca V., Fasola, Gianpiero, Aprile, Giuseppe
Published in Oncotarget (2016)

A streamlined workflow for single-cells genome-wide copy-number profiling by low-pass sequencing of LM-PCR whole-genome amplification products

by Ferrarini, Alberto, Forcato, Claudio, Buson, Genny, Tononi, Paola, del Monaco, Valentina, Terracciano, Mario, Bolognesi, Chiara, Fontana, Francesca, Medoro, Gianni, Neves, Rui, Möhlendick, Birte, Rihawi, Karim, Ardizzoni, Andrea, Sumanasuriya, Semini, Flohr, Penny, Lambros, Maryou, de Bono, Johann, Stoecklein, Nikolas H., Manaresi, Nicolò
Published in PLoS One (2018)

Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours

by de Bono, Johann, Lin, Chia-Chi, Chen, Li-Tzong, Corral, Jesus, Michalarea, Vasiliki, Rihawi, Karim, Ong, Michael, Lee, Jih-Hsiang, Hsu, Chih-Hung, Yang, James Chih-Hsin, Shiah, Her-Shyong, Yen, Chia-Jui, Anthoney, Alan, Jove, Maria, Buschke, Susanne, Fuertig, René, Schmid, Ulrike, Goeldner, Rainer-Georg, Strelkowa, Natalja, Huang, Dennis Chin-Lun, Bogenrieder, Thomas, Twelves, Chris, Cheng, Ann-Lii
Published in Br J Cancer (2020)